CARA - Cara Therapeutics - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

70.72M

Cash

114.3M

Avg Qtr Burn

-21.96M

Short % of Float

13.01%

Insider Ownership

14.37%

Institutional Own.

65.33%

Qtr Updated

03/31/23

Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Korsuva IV (CR845 IV) Details Pruritus with chronic kidney disease , Kidney disease	Approved Quarterly sales	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Oral Korsuva (CR845) Details Pruritus CKD (Chronic Kidney Disease) Stages 3 - 5	Phase 3 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Oral Korsuva (CR845) Details Skin disease/disorder, Inflammatory disease, Atopic dermatitis, Atopic pruritus	Phase 3 Interim Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Oral Korsuva (CR845) Details Chronic pruritus, Pruritus associated with notalgia paresthetica	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
Oral Korsuva (CR845) Details Chronic liver disease, Liver disease, Chronic pruritus, Hemophilia, Blood disorder	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.